Ally Bridge Group (NY) LLC Buys SomaLogic Inc, Rapid Micro Biosystems Inc, Sight Sciences Inc, Sells Cerevel Therapeutics Holdings Inc, ESSA Pharma Inc, Atea Pharmaceuticals Inc

• New Purchases: SLGC, RPID, SGHT, AMRS, LPTX, ISEE, BLI, VERV,
• Added Positions: NTRA, MGNX, IDYA, VRDN,
• Reduced Positions: CYT, NTLA, NVTA, RGEN, BOLT, BOLT, ARVN, NUVB,
• Sold Out: CERE, EPIX, AVIR, APLS, SBTX, FRLN,

For the details of Ally Bridge Group (NY) LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ally+bridge+group+%28ny%29+llc/current-portfolio/portfolio

1. Natera Inc (NTRA) - 268,000 shares, 9.48% of the total portfolio. Shares added by 22.94%
2. Repligen Corp (RGEN) - 70,000 shares, 6.42% of the total portfolio. Shares reduced by 15.15%
3. Arvinas Inc (ARVN) - 210,000 shares, 5.48% of the total portfolio. Shares reduced by 12.5%
4. Mirati Therapeutics Inc (MRTX) - 95,000 shares, 5.34% of the total portfolio.
5. Nuvation Bio Inc (NUVB) - 1,660,947 shares, 5.24% of the total portfolio. Shares reduced by 2.76%

Ally Bridge Group (NY) LLC initiated holding in SomaLogic Inc. The purchase prices were between $10.2 and $12.77, with an estimated average price of $11.41. The stock is now traded at around $13.280000. The impact to a portfolio due to this purchase was 3.15%. The holding were 800,000 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC initiated holding in Rapid Micro Biosystems Inc. The purchase prices were between $17.88 and $24.8, with an estimated average price of $20.63. The stock is now traded at around $15.900000. The impact to a portfolio due to this purchase was 2.57%. The holding were 437,960 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC initiated holding in Sight Sciences Inc. The purchase prices were between $22.34 and $39.1, with an estimated average price of $32.86. The stock is now traded at around $22.205000. The impact to a portfolio due to this purchase was 2.47%. The holding were 342,304 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC initiated holding in Amyris Inc. The purchase prices were between $12.13 and $16.99, with an estimated average price of $14.34. The stock is now traded at around $7.880000. The impact to a portfolio due to this purchase was 1.54%. The holding were 352,445 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC initiated holding in Leap Therapeutics Inc. The purchase prices were between $1.35 and $4.01, with an estimated average price of $1.87. The stock is now traded at around $2.399900. The impact to a portfolio due to this purchase was 1.53%. The holding were 1,200,000 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC initiated holding in IVERIC bio Inc. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $16.920000. The impact to a portfolio due to this purchase was 1.29%. The holding were 250,000 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC added to a holding in Natera Inc by 22.94%. The purchase prices were between $100.17 and $126.36, with an estimated average price of $114.79. The stock is now traded at around $114.270000. The impact to a portfolio due to this purchase was 1.77%. The holding were 268,000 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC added to a holding in Macrogenics Inc by 223.47%. The purchase prices were between $19.74 and $28.7, with an estimated average price of $24.13. The stock is now traded at around $19.700000. The impact to a portfolio due to this purchase was 1.68%. The holding were 365,000 shares as of 2021-09-30.

Ally Bridge Group (NY) LLC sold out a holding in Cerevel Therapeutics Holdings Inc. The sale prices were between $21.26 and $38.85, with an estimated average price of $28.11.

Ally Bridge Group (NY) LLC sold out a holding in ESSA Pharma Inc. The sale prices were between $7.76 and $29.37, with an estimated average price of $15.99.

Ally Bridge Group (NY) LLC sold out a holding in Atea Pharmaceuticals Inc. The sale prices were between $21.33 and $35.06, with an estimated average price of $27.69.

Ally Bridge Group (NY) LLC sold out a holding in Apellis Pharmaceuticals Inc. The sale prices were between $31.4 and $69.84, with an estimated average price of $56.51.

Ally Bridge Group (NY) LLC sold out a holding in Silverback Therapeutics Inc. The sale prices were between $9.98 and $35.22, with an estimated average price of $24.7.

Ally Bridge Group (NY) LLC sold out a holding in Freeline Therapeutics Holdings PLC. The sale prices were between $3.04 and $8.9, with an estimated average price of $4.78.